Biocryst Pharmaceuticals (BCRX) Asset Utilization Ratio (2011 - 2026)

Biocryst Pharmaceuticals' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.98 for Q1 2026.

• Quarterly Asset Utilization Ratio fell 5.54% year-over-year to 0.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.98 (down 5.54% YoY) and the FY2025 annual result came in at 1.74, up 94.64% from the prior year.
• Asset Utilization Ratio was 0.98 for Q1 2026 at Biocryst Pharmaceuticals, roughly flat from 0.98 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.33 in Q3 2025 and bottomed at 0.34 in Q1 2022.
• A 5-year average of 0.76 and a median of 0.72 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 225.55% — and 2026, when it decreased 5.54%.
• Biocryst Pharmaceuticals' Asset Utilization Ratio stood at 0.49 in 2022, then soared by 30.46% to 0.64 in 2023, then surged by 44.06% to 0.92 in 2024, then climbed by 6.34% to 0.98 in 2025, then advanced by 0.37% to 0.98 in 2026.
• Business Quant data shows BCRX's Asset Utilization Ratio at 0.98 in Q1 2026, 0.98 in Q4 2025, and 1.33 in Q3 2025.